Kura Oncology, Inc. (NASDAQ:KURA – Get Rating) – Stock analysts at Brookline Capital Management boosted their Q2 2023 earnings per share (EPS) estimates for Kura Oncology in a research report issued to clients and investors on Wednesday, May 10th. Brookline Capital Management analyst L. Cann now forecasts that the company will earn ($0.71) per share […]
Kura Oncology, Inc. (NASDAQ:KURA – Get Rating) – HC Wainwright upped their Q2 2023 earnings per share (EPS) estimates for shares of Kura Oncology in a report released on Thursday, May 11th. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings per share of ($0.54) for the quarter, up from their […]
Kura Oncology, Inc. (NASDAQ:KURA – Get Rating) – Analysts at Wedbush raised their FY2025 earnings per share (EPS) estimates for shares of Kura Oncology in a research note issued to investors on Thursday, May 11th. Wedbush analyst R. Driscoll now anticipates that the company will post earnings of $2.45 per share for the year, up […]
Denali Advisors LLC trimmed its holdings in Kura Oncology, Inc. (NASDAQ:KURA – Get Rating) by 41.5% in the fourth quarter, Holdings Channel reports. The fund owned 3,800 shares of the company’s stock after selling 2,700 shares during the period. Denali Advisors LLC’s holdings in Kura Oncology were worth $47,000 at the end of the most […]
Should You Buy or Sell Kura Oncology Stock? Get The Latest KURA Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.